目 录
第一章 中国人体器官捐献 1
一、机构和队伍建设情况 1
二、志愿登记情况 3
三、器官捐献情况 5
四、相关工作开展 7
五、工作展望 9
第二章 中国人体捐献器官获取 10
一、人体捐献器官获取体系建设与发展 11
二、OPO机构分布与建设情况 12
三、器官捐献情况 13
四、器官获取与利用情况 14
五、捐献器官质量情况 16
六、特点与展望 18
第三章 中国人体器官分配与共享 20
一、中国移植医疗机构分布 22
二、人体器官捐献情况 22
三、移植等待者情况 24
四、人体器官分配与共享政策实施效果 28
五、特点与展望 30
第四章 中国肝脏移植 32
一、肝脏移植医疗机构分布 33
二、肝脏移植受体人口特征 35
三、肝脏移植质量安全分析 36
四、特点与展望 39
第五章 中国肾脏移植 41
一、肾脏移植医疗机构分布 42
二、肾脏移植受体人口特征 48
三、肾脏移植质量安全分析 49
四、特点与展望 51
第六章 中国心脏移植 53
一、心脏移植医疗机构分布 53
二、心脏移植受体人口特征 56
三、心脏移植质量安全分析 57
四、特点与展望 59
第七章 中国肺脏移植 61
一、肺脏移植医疗机构分布 62
二、肺脏移植受体人口特征 64
三、肺脏移植质量安全分析 66
四、特点与展望 70
第八章 中国器官移植技术进展与创新 73
一、劈离式肝移植关键技术体系建立和推广 73
二、甲胎蛋白-谷氨酰转肽酶-杭州标准评分（AFP-GGT-
Hangzhou scoring system，AGH评分）是肝细胞癌患者
肝移植术后无病生存和靶向治疗效果的预测指标 75
三、融合双分子标志物的肝癌肝移植患者分类新标准 79
四、天然高分子生物肝材料治疗多器官功能衰竭核心技术
体系的建立与应用 80
五、基于基因模型指导肝移植术后抗排异反应精准给药方案 82
六、达芬奇机器人辅助腹腔镜技术在肾移植中的应用 83
七、人工血管保护外鞘预防移植肾动脉扭折的疗效 86
八、六基因编辑猪-恒河猴异种肾脏移植 88
九、国内首组婴幼儿供肾给婴幼儿肾移植37例 90
十、无缺血心脏移植 91
十一、一种全新的心肌活检技术在心脏移植术后的应用 92
十二、基于机器学习的肺移植患者预后模型 94
十三、机器人辅助微创入路单肺移植手术 95
十四、供体来源游离DNA在肺移植术后排异反应
诊断中的应用 97
索 引 99
Contents
Chapter 1 Human Organ Donation in China 101
1.1 Organizations and team building 102
1.2 Registration of human organ donation volunteers 105
1.3 Organ donation in China 107
1.4 Progress of related work 109
1.5 Future outlook 113
Chapter 2 Donated Organ Procurement in China 115
2.1 Development and construction of human donated organ
procurement system 116
2.2 Distribution and construction of OPOs 118
2.3 Organ donation in China 119
2.4 Procurement and utilization of organs 121
2.5 Quality of donor organs 123
2.6 Features and future outlook 125
Chapter 3 Human Organ Allocation and Sharing in China 129
3.1 Distribution of transplant hospitals in China 132
3.2 Overview of human organ donation 133
3.3 Patients waiting for organ transplantation 135
3.4 Policy implementation efficacy in organ allocation and sharing 140
3.5 Feature and future outlook 142
Chapter 4 Liver Transplantation in China 145
4.1 Distribution of medical institutions qualified for liver
transplantation 146
4.2 Demographic characteristics of liver transplant recipients 149
4.3 Quality and safety analysis of liver transplantation 150
4.4 Feature and future outlook 153
Chapter 5 Kidney Transplantation in China 156
5.1 Distribution of medical institutions qualified for kidney transplantation 157
5.2 Demographic characteristics of kidney transplant recipients 165
5.3 Quality and safety analysis of kidney transplantation 166
5.4 Feature and future outlook 169
Chapter 6 Heart Transplantation in China 172
6.1 Distribution of medical institutions qualified for heart transplantation 173
6.2 Demographic characteristics of heart transplant recipients 175
6.3 Quality and safety analysis of heart transplantation 177
6.4 Feature and future outlook 179
Chapter 7 Lung Transplantation in China 183
7.1 Distribution of medical institutions qualified for lung
transplantation 184
7.2 Demographic characteristics of lung transplant recipients 187
7.3 Quality and safety analysis of lung transplantation 190
7.4 Feature and future outlook 195
Chapter 8 The Development of Technologies and Innovations for Organ Transplantation in China 199
8.1 Establishment and promotion of key technical system for split liver transplantation 199
8.2 The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma 202
8.3 A novel stratification integrating dual biomarkers in liver transplantation for hepatocellular carcinoma 206
8.4 Establishment and application of core technology system for the treatment of multiple organ failure with natural polymer biological liver materials 208
8.5 Genotype-guided model used for precise anti-rejection therapy after liver transplantation 211
8.6 Application of Da Vinci robot-assisted laparoscopy in kidney transplantation 213
8.7 The utilization of an artificial protective external vascular sheath in renal transplantation represents a novel technological advancement aimed at preventing graft artery kinking 217
8.8 Six-genes edited porcine-rhesus kidney xenotran-splantation 219
8.9 The first group of 37 cases of kidney transplantation for infants and young children in China 221
8.10 Ischemia-free heart transplantation 224
8.11 A novel myocardial biopsy technique after heart
transplantation 225
8.12 A machine learning based prognostic model for lung
transplant patients 228
8.13 Robot-assisted lung transplantation 230
8.14 Application of donor-derived cell-free DNA in diagnosing
rejection after lung transplantation 232
